Patents by Inventor Jane REED

Jane REED has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REAGENTS, METHODS AND KITS FOR IDENTIFYING PREGNANT HUMAN BEINGS AT RISK FOR PLACENTAL BED DISORDER(S)
    Publication number: 20230332234
    Abstract: This disclosure provides microRNA (miRNA)-based tests and treatment protocols for identifying and/or treating pregnant human beings at risk for a placental bed disorder during pregnancy, as well as reagents and/or kits relating to the same.
    Type: Application
    Filed: September 21, 2021
    Publication date: October 19, 2023
    Applicant: EWINGER, INC.
    Inventors: Edward WINGER, Jane REED
  • Methods and Compositions for Assessing Patients with Preeclampsia-Related Conditions Using MicroRNA
    Publication number: 20220325345
    Abstract: The invention is directed to methods and compositions for collecting a non-placental biological samples of cells and quantifying and comparing levels of expression of microRNAs to characterize a preeclampsia-related condition. The samples may be collected before or after an intervention or may be collected over a period of time. One of the samples may be a control sample. Patients may then be treated according to their response.
    Type: Application
    Filed: February 4, 2022
    Publication date: October 13, 2022
    Applicant: EWINGER INC.
    Inventors: Edward E. WINGER, Jane REED
  • REAGENTS, METHODS AND KITS FOR IDENTIFYING PREGNANT HUMAN BEINGS AT RISK FOR PLACENTAL BED DISORDER(S)
    Publication number: 20220177967
    Abstract: This disclosure provides microRNA (miRNA)-based tests and treatment protocols for identifying and/or treating pregnant human beings at risk for a placental bed disorder during pregnancy, as well as reagents and/or kits relating to the same.
    Type: Application
    Filed: March 6, 2020
    Publication date: June 9, 2022
    Applicant: EDWARD E. WINGER, M.D., PROFESSIONAL CORPORATION
    Inventors: Edward WINGER, Jane REED
  • Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
    Patent number: 6310088
    Abstract: Compounds of formula (I) are useful therapeutic agents, by virtue of having MMP and TNF inhibitory activity.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: October 30, 2001
    Assignee: Darwin Discovery, Ltd.
    Inventors: Andrew Douglas Baxter, David Alan Owen, John Gary Montana, Elizabeth Jane Reed Nicholson